Search
for
Sort by
Research 541–570 of 1000+
- Dietary Habits in Japanese Patients with Alopecia Areata
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Cytokine Engineering Approaches for Regenerative Medicine
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Alopecia and Periodontitis: Exploring the connecting dots
- Netherton syndrome: effect on ichthyosis linearis circumflexa with dupilumab
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Acne Syndromes and Mosaicism
- Molecular cytokine-dependent mechanisms of periodontitis pathogenesis and the potential for pharmacological IL-1 modulation in disease treatment
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Exosome-Based Therapeutics in Dermatology and Beyond: A Narrative Review
- The Intervention Effect of Externally Applying or Orally Administering Bifidobacterium animalis Subsp. lactis J12 on Atopic Dermatitis Induced by 2,4-Dinitrofluorobenzene
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- Immunopharmacological potential of Arctium lappa L. in immune-mediated skin diseases: A critical review of experimental and clinical evidence
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- The Effects of Environmental Pollutants and Exposures on Hair Follicle Pathophysiology
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Skin-associated adipocytes in skin barrier immunity: A mini-review
- Bacteroides fragilis and Microbacterium as Microbial Signatures in Hashimoto’s Thyroiditis
- Serum 25 hydroxyvitamin D in non‐scarring alopecia: A systematic review and meta‐analysis
- Tregs: Where We Are and What Comes Next?
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases